General Information of the Cell Line
Cell Line ID
CL000663
Cell Line Name
IEC-6
Synonyms
IEC 6
IEC6
Intestinal Epithelioid Cell line No. 6
Category
Finite cell line
Organism
Rattus norvegicus (Rat)
Cellosaurus ID
CVCL_0343
Tissue Information
Small intestine
Disease None
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT06622, X-box-binding protein 1
Compound ID Compound Name Compound Formula
CP0533972
N-(4-methylphenyl)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-imine
   Show/Hide
C26H20N2O4
 1
1
EC50 = 13.2 nM
   TI
   LI
   LO
   TS
CP0482956
N-(5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-ylidene)pentanamide
   Show/Hide
C24H22N2O5
 1
1
EC50 = 32.5 nM
   TI
   LI
   LO
   TS
CP0460962
N-(4-bromophenyl)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-imine
   Show/Hide
C25H17BrN2O4
 1
1
EC50 = 48.9 nM
   TI
   LI
   LO
   TS
CP0544526
N-(5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-ylidene)hexanamide
   Show/Hide
C25H24N2O5
 1
1
EC50 = 70.8 nM
   TI
   LI
   LO
   TS
CP0473125
5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-one
   Show/Hide
C19H13NO5
 2
1
EC50 = 79.8 nM
   TI
   LI
   LO
   TS
2
EC50 = 80 nM
   TI
   LI
   LO
   TS
CP0544525
N-phenyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-imine
   Show/Hide
C25H18N2O4
 1
1
EC50 = 113 nM
   TI
   LI
   LO
   TS
CP0490335
N-(4-chlorophenyl)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-imine
   Show/Hide
C25H17ClN2O4
 1
1
EC50 = 174 nM
   TI
   LI
   LO
   TS
CP0567874
N-(4-methoxyphenyl)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-imine
   Show/Hide
C26H20N2O5
 1
1
EC50 = 184 nM
   TI
   LI
   LO
   TS
CP0539623
N-(5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-ylidene)butanamide
   Show/Hide
C23H20N2O5
 1
1
EC50 = 199 nM
   TI
   LI
   LO
   TS
CP0574784
N-(5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-ylidene)acetamide
   Show/Hide
C21H16N2O5
 1
1
EC50 = 283 nM
   TI
   LI
   LO
   TS
CP0460963
N-(5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-ylidene)propanamide
   Show/Hide
C22H18N2O5
 1
1
EC50 = 289 nM
   TI
   LI
   LO
   TS
CP0466908
(1S,2R,4S,7R,8R,10Z,12R)-1,7,11-trimethyl-4-propan-2-yl-15,16-dioxatricyclo[10.2.1.14,7]hexadec-10-ene-2,8-diol
   Show/Hide
C20H34O4
 1
1
EC50 = 340 nM
   TI
   LI
   LO
   TS
CP0490283
N-(4-fluorophenyl)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-imine
   Show/Hide
C25H17FN2O4
 1
1
EC50 = 346 nM
   TI
   LI
   LO
   TS
CP0407579
(1S,3R,5R,8E,12R,13R)-12-hydroxy-5,9,13-trimethyl-1-propan-2-yl-4,16-dioxatricyclo[11.2.1.03,5]hexadec-8-en-10-one
   Show/Hide
C20H32O4
 1
1
EC50 = 420 nM
   TI
   LI
   LO
   TS
CP0403029
(1S,3R,5R,7S,8E,12R,13R)-7,12-dihydroxy-5,9,13-trimethyl-1-propan-2-yl-4,16-dioxatricyclo[11.2.1.03,5]hexadec-8-en-10-one
   Show/Hide
C20H32O5
 1
1
EC50 = 880 nM
   TI
   LI
   LO
   TS
CP0519877
(1S,3R,5R,8Z,12R,13R)-12-hydroxy-5,13-dimethyl-1-propan-2-yl-4,16-dioxatricyclo[11.2.1.03,5]hexadec-8-ene-9-carbaldehyde
   Show/Hide
C20H32O4
 1
1
EC50 = 1140 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0139001
N-(4-fluorophenyl)-1-methyl-3-[[methyl-[2-(4-phenylphenyl)ethyl]amino]methyl]indole-5-carboxamide
   Show/Hide
C32H30FN3O  1
1
IC50 = 6430 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Small intestine)
Cell Line Name Organism Disease
HuTu 80 Homo sapiens (Human) Duodenal adenocarcinoma